Live Webinars

Presenter: Chantelle Thomas, Ph.D. Dr. Chantelle Thomas, Executive Clinical Director of Windrose Recovery, is a Clinical Health Psychologist specializing in the treatment of addiction and trauma. Since 2013, she has been studying the therapeutic use of psychedelics for individuals with PTSD, substance use disorders, and depression via clinical and mechanistic research trials at University of Wisconsin School of Medicine and Public Health. She is certified in both MDMA-Assisted Psychotherapy and Ketamine Assisted Psychotherapy (KAP) and established Integrata, an integrative KAP treatment program that implements a relational, inner-directed model for trauma reprocessing for both residential and outpatient clients. She is directly involved in teaching, training, and consulting with clinical trials in the academic and private sector involving LSD, MDMA, Psilocybin, Ketamine, and 5-MeO-DMT. She also hosts a podcast, Blind Spots: Exploring What We Cannot See, that explores therapeutic blind spots in both established and novel treatments for substance use and trauma-related conditions.  

 Overview:          This webinar will review the critical aspects of the therapeutic model and approach that is used in psychedelic-assisted therapy. The three main stages of PAT, preparation, dosing and integration sessions, will be defined and described. The importance of “set and setting” will also be illustrated. Lastly, the psychotherapeutic modalities that contribute to the PAT approach will be explored, which include relational therapy, humanistic and Rogerian client-centered therapy, as well as a central focus on cultural humility.

Learning Objectives: 

1. Explain the range of psychedelic subjective effects as impacted by
2. Discuss the stages of psychedelic assisted therapy and the importance of each stage in the arc of PAT
3. Describe the role of therapists/facilitators in supporting an inner-directed process and a paradigm shift that de-centers practitioners’ as experts

The Society of Clinical Psychology, Division 12 does not have commercial support for the content of this webinar including endorsement of products, conflict of interest including but not limited to research grants, royalties for books or training, commercial support from companies or pharmaceutical sponsorship. 

Dr. Thomas is a clinical consultant and/or educator for Lykos, Mindmed, Usona Institute, Fluence, Polaris. I am a part owner of Integrata. If you require any special needs assistance, please contact the SCP Central Office at [email protected]. 

Presenter:  J. Kim Penberthy, Ph.D., ABPP Dr. J. Kim Penberthy is a board-certified clinical psychologist and Professor of Psychiatry and Neurobehavioral Sciences at the University of Virginia School of Medicine. She specializes in the integration of contemplative practices—such as mindfulness, self-compassion, and meaning-centered interventions—into psychotherapy and clinical care. Her work focuses on serious illness, end-of-life concerns, and spiritual and existential aspects of psychological wellbeing. Dr. Penberthy has published extensively on mindfulness-based interventions, spiritual and religious issues in clinical practice, and the interface between science and contemplative wisdom. She is a founding member of the UVA Contemplative Sciences Center and has led national workshops and trainings on integrating mindfulness and meaning-making into medical and psychological care. Her clinical experience includes working with individuals facing terminal illness, prolonged grief, and death anxiety. Her background uniquely qualifies her to speak on how contemplative approaches can support individuals navigating fear of death and grief after loss, while also training clinicians to recognize and respond to non-ordinary experiences in a respectful, non-pathologizing manner.   Overview:          In both clinical and contemplative settings, individuals frequently report experiences that fall outside ordinary waking consciousness—such as near-death experiences, after-death communications, spiritual awakenings, and spontaneous mystical states. While these may superficially resemble psychopathological symptoms (e.g., hallucinations, dissociation, delusions), many such experiences are deeply meaningful, culturally normative, or even transformative. Clinicians and researchers are increasingly called upon to make nuanced distinctions between psychopathology and non-ordinary experiences (NOEs), especially in contexts of grief, trauma, spiritual practice, or end-of-life care. This session explores the complexity of this clinical discernment. Participants will learn frameworks for distinguishing between pathology and non-pathology, considering factors such as: intact reality testing, cultural context, degree of distress or functional impairment, and the presence of integration or insight following the experience (Lukoff, Lu, & Turner, 1998; Grof & Grof, 1989). We will also examine how diagnostic systems such as the DSM-5 acknowledge spiritual or religious experiences through the "Religious or Spiritual Problem" V code (American Psychiatric Association, 2013). Drawing from transpersonal psychology, contemplative science, and trauma-informed care, we advocate for an integrative and culturally sensitive approach that avoids pathologizing the extraordinary. Case studies will illustrate how misdiagnosis can lead to unnecessary treatment, while respectful inquiry and meaning-centered dialogue can facilitate posttraumatic growth and healing (Corcoran & Walsh, 2010; Greyson, 2000). This session invites participants to explore how clinicians, caregivers, and contemplative practitioners can skillfully hold space for NOEs—balancing curiosity and compassion with clinical responsibility.

Learning Objectives: Intended Audience: Intermediate

1. Describe the diagnostic criteria approach for psychiatric disorders, including what defines a psychopathology.
2. Describe non-ordinary experiences that patients may report, including spontaneous and induced experiences such as near death experiences and out-of-body experiences.
3. Describe how to approach a patient who is reporting non-ordinary experiences in order to optimize understanding and healing.

The Society of Clinical Psychology, Division 12 and Dr. Penberthy do not have commercial support for the content of this webinar including endorsement of products, conflict of interest including but not limited to research grants, royalties for books or training, commercial support from companies or pharmaceutical sponsorship. If you require any special needs assistance, please contact the SCP Central Office at [email protected].